JP2005521632A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005521632A5 JP2005521632A5 JP2003512371A JP2003512371A JP2005521632A5 JP 2005521632 A5 JP2005521632 A5 JP 2005521632A5 JP 2003512371 A JP2003512371 A JP 2003512371A JP 2003512371 A JP2003512371 A JP 2003512371A JP 2005521632 A5 JP2005521632 A5 JP 2005521632A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- nucleic acid
- patient
- foreign nucleic
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 210000004027 cell Anatomy 0.000 claims 39
- 238000000034 method Methods 0.000 claims 36
- 150000007523 nucleic acids Chemical class 0.000 claims 26
- 108020004707 nucleic acids Proteins 0.000 claims 24
- 102000039446 nucleic acids Human genes 0.000 claims 24
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims 14
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims 14
- 210000000777 hematopoietic system Anatomy 0.000 claims 12
- 230000037396 body weight Effects 0.000 claims 8
- 210000004976 peripheral blood cell Anatomy 0.000 claims 8
- 230000036436 anti-hiv Effects 0.000 claims 6
- 238000001574 biopsy Methods 0.000 claims 6
- 108090000994 Catalytic RNA Proteins 0.000 claims 5
- 102000053642 Catalytic RNA Human genes 0.000 claims 5
- 108091092562 ribozyme Proteins 0.000 claims 5
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 230000000840 anti-viral effect Effects 0.000 claims 3
- 210000001185 bone marrow Anatomy 0.000 claims 3
- 210000002798 bone marrow cell Anatomy 0.000 claims 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims 2
- 210000005105 peripheral blood lymphocyte Anatomy 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- 238000011529 RT qPCR Methods 0.000 claims 1
- 230000000692 anti-sense effect Effects 0.000 claims 1
- 238000002617 apheresis Methods 0.000 claims 1
- 238000010322 bone marrow transplantation Methods 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 238000001415 gene therapy Methods 0.000 claims 1
- 230000003394 haemopoietic effect Effects 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 230000003834 intracellular effect Effects 0.000 claims 1
- 210000004698 lymphocyte Anatomy 0.000 claims 1
- 238000002271 resection Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30428301P | 2001-07-10 | 2001-07-10 | |
| US34339201P | 2001-10-22 | 2001-10-22 | |
| PCT/US2002/021713 WO2003006612A2 (en) | 2001-07-10 | 2002-07-10 | Production of transduced hematopoietic progenitor cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005521632A JP2005521632A (ja) | 2005-07-21 |
| JP2005521632A5 true JP2005521632A5 (https=) | 2006-01-05 |
Family
ID=26973926
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003512371A Withdrawn JP2005521632A (ja) | 2001-07-10 | 2002-07-10 | 形質導入造血前駆細胞の生産 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20030082158A1 (https=) |
| EP (1) | EP1418814A4 (https=) |
| JP (1) | JP2005521632A (https=) |
| KR (1) | KR20040084885A (https=) |
| CN (1) | CN1551728A (https=) |
| BR (1) | BR0211066A (https=) |
| CA (1) | CA2453187A1 (https=) |
| IL (1) | IL159777A0 (https=) |
| WO (1) | WO2003006612A2 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020058636A1 (en) * | 1994-09-21 | 2002-05-16 | Geoffrey P. Symonds | Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| US7994144B2 (en) | 2001-07-10 | 2011-08-09 | Johnson & Johnson Research Pty, Limited | Process for the preparation of a composition of genetically modified hematopoietic progenitor cells |
| JP5179697B2 (ja) | 2001-07-10 | 2013-04-10 | ジョンソン・アンド・ジョンソン・リサーチ・プロプライエタリー・リミテッド | 造血前駆細胞を遺伝的に改変する方法及び改変された細胞の使用 |
| IL162130A0 (en) * | 2001-12-07 | 2005-11-20 | Robarts Res Inst | Hematopoietic cells from human embryonic stem cells |
| US7799324B2 (en) | 2001-12-07 | 2010-09-21 | Geron Corporation | Using undifferentiated embryonic stem cells to control the immune system |
| AU2003294029A1 (en) * | 2002-11-06 | 2004-06-07 | L'oreal | Composition containing a semi-crystalline polymer and a pasty fatty substance |
| FR2846554B1 (fr) * | 2002-11-06 | 2007-02-09 | Oreal | Composition contenant un polymere semi-cristallin et un corps gras pateux |
| GB0410130D0 (en) * | 2004-05-06 | 2004-06-09 | Molmed Spa | Cell preparation |
| WO2012074068A1 (ja) | 2010-12-01 | 2012-06-07 | 日産化学工業株式会社 | ピラゾール化合物による造血幹細胞の製造方法 |
| US11697799B2 (en) | 2019-04-15 | 2023-07-11 | Ossium Health, Inc. | System and method for extraction and cryopreservation of bone marrow |
| EP4181675A4 (en) | 2020-07-18 | 2024-04-24 | Ossium Health, Inc. | PERMEATION OF WHOLE VERTEBRATE BODIES WITH A CRYOPRETECTIVE AGENT USING VACUUM-ASSISTED DIFFUSION |
| CA3195653A1 (en) | 2020-10-14 | 2022-04-21 | Ossium Health, Inc. | Systems and methods for extraction and cryopreservation of bone marrow |
| WO2022133282A1 (en) | 2020-12-18 | 2022-06-23 | Ossium Health, Inc. | Methods of cell therapies |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5500357A (en) * | 1990-11-02 | 1996-03-19 | Agency Of Industrial Science & Technology, Ministry Of International Trade & Industry | RNA transcription system using novel ribozyme |
| US5693535A (en) * | 1992-05-14 | 1997-12-02 | Ribozyme Pharmaceuticals, Inc. | HIV targeted ribozymes |
| US5525468A (en) * | 1992-05-14 | 1996-06-11 | Ribozyme Pharmaceuticals, Inc. | Assay for Ribozyme target site |
| US5911983A (en) * | 1992-06-26 | 1999-06-15 | University Of Pittsburgh | Gene therapy for Gaucher disease using retroviral vectors |
| US5712384A (en) * | 1994-01-05 | 1998-01-27 | Gene Shears Pty Ltd. | Ribozymes targeting retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| US20020058636A1 (en) * | 1994-09-21 | 2002-05-16 | Geoffrey P. Symonds | Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| US7994144B2 (en) * | 2001-07-10 | 2011-08-09 | Johnson & Johnson Research Pty, Limited | Process for the preparation of a composition of genetically modified hematopoietic progenitor cells |
| JP5179697B2 (ja) * | 2001-07-10 | 2013-04-10 | ジョンソン・アンド・ジョンソン・リサーチ・プロプライエタリー・リミテッド | 造血前駆細胞を遺伝的に改変する方法及び改変された細胞の使用 |
-
2002
- 2002-07-10 CA CA002453187A patent/CA2453187A1/en not_active Abandoned
- 2002-07-10 JP JP2003512371A patent/JP2005521632A/ja not_active Withdrawn
- 2002-07-10 CN CNA028174879A patent/CN1551728A/zh active Pending
- 2002-07-10 BR BRPI0211066-0A patent/BR0211066A/pt not_active IP Right Cessation
- 2002-07-10 US US10/192,058 patent/US20030082158A1/en not_active Abandoned
- 2002-07-10 IL IL15977702A patent/IL159777A0/xx unknown
- 2002-07-10 EP EP02749878A patent/EP1418814A4/en not_active Withdrawn
- 2002-07-10 KR KR10-2004-7000432A patent/KR20040084885A/ko not_active Withdrawn
- 2002-07-10 WO PCT/US2002/021713 patent/WO2003006612A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111278976B (zh) | 一种提高胎儿血红蛋白表达的方法 | |
| ES2553712T3 (es) | Células adherentes de la placenta y uso de las mismas en el tratamiento de enfermedad | |
| IL308706A (en) | Compositions and methods for the treatment of hemoglobinopathies | |
| US20070053888A1 (en) | Use of umbilical cord blood to treat individuals having a disease, disorder or condition | |
| JP2020505934A5 (https=) | ||
| JP2005521632A5 (https=) | ||
| JP2019520844A5 (https=) | ||
| JP2017513477A5 (https=) | ||
| AU2018337672A1 (en) | Non-integrating DNA vectors for the genetic modification of cells | |
| EP4017512B1 (en) | Compositions for monocyte and macrophage polarization and methods of use | |
| US20240181005A1 (en) | Compositions, systems, and methods for generating gene-edited cells | |
| WO2012065024A1 (en) | Compositions, cells, kits and methods for autologous stem cell therapy | |
| WO2025261231A1 (zh) | 高度靶向人类HLA-A基因的sgRNA、其组合物及应用 | |
| Ambrożej et al. | “Liquid biopsy”-extracellular vesicles as potential novel players towards precision medicine in asthma | |
| JP2005521632A (ja) | 形質導入造血前駆細胞の生産 | |
| CN110616233A (zh) | CRISPR-Cas9高效敲除原代T细胞基因的方法及其应用 | |
| He et al. | MIP-3α and MIP-1α rapidly mobilize dendritic cell precursors into the peripheral blood | |
| CN118406718A (zh) | 一种提高nk细胞功能的方法 | |
| Goryaev et al. | Genome-editing and biomedical cell products: current state, safety and efficacy | |
| CN115518060A (zh) | 衣康酸及其衍生物在治疗白癜风药物上的应用及其治疗白癜风的药物 | |
| US20250241961A1 (en) | Stem cell immunotherapy for colitis | |
| US20260071213A1 (en) | Compositions targeting hbg1 and hbg2 and methods of use thereof | |
| CN116098126B (zh) | 一种可特异性清除mhcii+脂肪细胞的基因工程小鼠及mhcii+脂肪细胞的制备方法及应用 | |
| WO2025157154A1 (zh) | 一种鉴定靶标的方法及其应用 | |
| CN118403176A (zh) | 一种干扰素腺病毒纳米囊泡及其作为载药递送系统的应用 |